Kalpana Verma, Anil kumar Panwar, Kakarla Mourya, Vigya Goyal and Birbal Baj
Page: 317-323 | Received 19 Jun 2023, Published online: 03 Jul 2023
Full Text Reference XML File PDF File
Fluid therapy is an important linchpin in perioperative management and it may influence clinical outcome and the use of health care resources, particularly after major surgery. to compare the clinical impact of intraoperative goal directed fluid therapy versus restrictive fluid therapy in patients undergoing major abdominal surgery. A total of 60 patients were randomized in the goal‐directed fluid therapy and restrictive fluid therapy groups. In case of goal directed fluid therapy (GDFT) baseline readings of pulse pressure variation (PPV) will be noted and PPV will be maintained in between 10‐13%. The primary goal was to see for fluid related complications and length of hospital stay. Secondary goal is hemodynamic changes. In case of restrictive fluid therapy (RFT) fluid was given at fixed rate of 4 mL kgG1. Phenylephrine 10 mcg iv bolus dose was given to maintain mean arterial pressure (MAP) above 65 mm Hg when there was drop in MAP <65 mm Hg. Intra operatively, the goal‐directed fluid therapy group received higher intravenous fluid volumes (mean of 1125 mL for each surgery and standard deviation of 255.002) compared with the restrictive fluid therapy group (mean of 713.33 mL for each surgery and standard deviation of 142.595, p<0.001). We concluded that Goal‐directed fluid therapy and a restrictive fluid therapy regimen are equally effective and don’t have any additional benefits over one other regarding fluid related complications, length of hospital stay and haemodynamic stability, when used in major abdominal surgeries.
Kalpana Verma, Anil kumar Panwar, Kakarla Mourya, Vigya Goyal and Birbal Baj. Periopreative Goal Directed Fluid Therapy Versus Restrictive Fluid Therapy for Adults Undergoing Major Abdominal Surgeries.
DOI: https://doi.org/10.36478/10.36478/makrjms.2023.317.323
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2023.317.323